Irbesartan vs Pembrolizumab

## Irbesartan vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Irbesartan** and **Pembrolizumab**.

## Mechanism of Action

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Irbesartan — 11-15 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Irbesartan — C25H28N6O; Pembrolizumab — N/A.

**Molecular Weight**: Irbesartan — 428.5320 g/mol; Pembrolizumab — N/A.

**Type**: Irbesartan — Small molecule; Pembrolizumab — Antibody.